MarketWatch  19 min ago  Comment 
Newlink Genetic Corp. shares fell in the extended session Monday after the biotech said it will continue a pancreatic cancer drug clinical trial without any modification to the study plan. Newlink shares fell 17% to $43.16 on moderate volume....
GenEng News  6 hrs ago  Comment 
The spare bedroom of Steve Jobs’ parents’ Los Alto, CA, home was where he and partners Steve Wozniak and Ronald G. Wayne manufactured the first Apple computers. A few months later as business began to take off, they moved to roomier...
FierceBiotech  8 hrs ago  Comment 
Commit up to $485 million to buy a cancer genomics company. Pay another $450 million for a share of an immuno-oncology candidate. Throw in a $30 million licensing deal and an $80 million bet on a longtime collaborator and you've got a month in the...
Benzinga  8 hrs ago  Comment 
Leerink analysts have initiated coverage of two biotechnology companies with an Outperform rating. The price target for Aduro BioTech Inc (NASDAQ: ADRO) is set at $48, while that for Cidara Therapeutics Inc (NASDAQ: CDTX) is set for $24. Aduro...
Benzinga  8 hrs ago  Comment 
Benzinga  9 hrs ago  Comment 
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections, today announced that the U.S. Food and Drug Administration (FDA) has designated the...
Motley Fool  May 10  Comment 
BioMarin Therapeutic Inc. and Amicus Therapeutics, Inc. are working on ultra-rare disease drugs that could attract an acquirer.
Benzinga  May 9  Comment 
After a decidedly dismal start to the week, the Friday non-farm payrolls report lifted the spirits of traders and managed to dig stocks out of the hole. The Department of Labor reported an increase of 223,000 jobs last month, which continues to...
Motley Fool  May 9  Comment 
Many think American manufacturing will remain globally noncompetitive for the foreseeable future, but biotech could change that in a big way.
Wall Street Journal  May 9  Comment 
An FDA advisory committee on Tuesday will consider whether to recommend approval of biotech Vertex’s experimental cystic-fibrosis drug, Orkambi.


Related Articles


Biotechnology is the use of molecular biology and genetic engineering techniques to develop treatments for human diseases. Many leading companies from the industry originated in the late 70's from university research laboratories. In the 1980s after attracting venture investors and after listed in the US stock exchange,have then developed into a growing industry that uses research innovations to develop new agricultural products, biomedical tools, and human therapies such as monoclonal antibody for cancer. In 2006, 92% of employees in the biotechnology industry worked in companies that specialized in developing new drugs or medical devices and equipment, while 8% were employed in companies that specialized in agricultural products. [1] The large cap company in the group is Amgen, Genentech, Biogen-Idec, Genzyme. iShares Nasdaq Biotechnology (IBB) offers a low risk/reward investment vehicle for long term investors

Industry Information

Major Biotechnology Companies

ISTA Pharmaceuticals (ISTA)

Biotechnology Industry Trends & Forces

High Pipeline Risk for New Drugs

Dependence on Health Insurance/Medicare Coverage

Dependence on Governmental Regulations

High Volatility and Instability at Start-up

Litigation Risk

Market Share


  1. State Bioscience Initiatives 2008 Report, published by the Biotechnology Industry Organization

Top Ten/Twenty Best Selling Drugs 2009

M&A Biotechnology

Monoclonal Antibody Market 2009

Vaccine Market 2009

Global Monoclonal Antibodies Market Review 2008 (World Top Ten mAbs)

M&A Review: Pharmaceutical & Biotechnology Industry

Global Vaccine Market Review 2008 (World Top Ten Vaccines)

Ipilimumab (BMS) Review: A Cancer Breakthrough?

Denosumab (Prolia, Amgen) FDA Review & Approval

Companies in the Biotechnology Industry (193)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki